Danaher Co. (NYSE:DHR) has been assigned a consensus rating of “Buy” from the twenty-two brokerages that are presently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, four have given a hold recommendation, sixteen have given a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $103.20.
A number of analysts have recently weighed in on the company. Zacks Investment Research upgraded Danaher from a “hold” rating to a “buy” rating and set a $112.00 target price for the company in a research report on Thursday. Credit Suisse Group upped their target price on Danaher from $106.00 to $108.00 and gave the company an “outperform” rating in a research report on Tuesday, March 13th. Deutsche Bank cut their target price on Danaher from $114.00 to $107.00 and set a “buy” rating for the company in a research report on Thursday, March 1st. Barclays assumed coverage on Danaher in a research report on Thursday, February 15th. They set an “overweight” rating and a $110.00 target price for the company. Finally, Argus upped their target price on Danaher from $100.00 to $115.00 and gave the company a “buy” rating in a research report on Thursday, February 1st.
In other Danaher news, insider Rainer Blair sold 3,981 shares of the company’s stock in a transaction dated Monday, February 26th. The stock was sold at an average price of $100.05, for a total value of $398,299.05. Following the completion of the transaction, the insider now owns 49,751 shares of the company’s stock, valued at approximately $4,977,587.55. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director John T. Schwieters sold 10,578 shares of the company’s stock in a transaction dated Monday, February 26th. The stock was sold at an average price of $100.30, for a total value of $1,060,973.40. Following the completion of the transaction, the director now directly owns 29,531 shares of the company’s stock, valued at approximately $2,961,959.30. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 313,260 shares of company stock valued at $31,657,786. 12.20% of the stock is owned by corporate insiders.
DHR stock traded down $1.55 during trading hours on Wednesday, hitting $95.94. The stock had a trading volume of 2,472,428 shares, compared to its average volume of 2,273,515. The company has a market cap of $68,006.05, a P/E ratio of 27.18, a price-to-earnings-growth ratio of 2.05 and a beta of 1.03. The company has a current ratio of 1.43, a quick ratio of 1.05 and a debt-to-equity ratio of 0.39. Danaher has a 1 year low of $78.97 and a 1 year high of $104.82.
Danaher (NYSE:DHR) last released its earnings results on Tuesday, January 30th. The conglomerate reported $1.19 earnings per share for the quarter, beating analysts’ consensus estimates of $1.16 by $0.03. The firm had revenue of $5.09 billion during the quarter, compared to the consensus estimate of $4.97 billion. Danaher had a return on equity of 11.36% and a net margin of 13.60%. The company’s revenue was up 10.9% compared to the same quarter last year. During the same period in the prior year, the company posted $1.05 EPS. analysts expect that Danaher will post 4.38 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 27th. Investors of record on Thursday, March 29th will be given a dividend of $0.16 per share. This is an increase from Danaher’s previous quarterly dividend of $0.14. This represents a $0.64 annualized dividend and a dividend yield of 0.67%. The ex-dividend date of this dividend is Wednesday, March 28th. Danaher’s dividend payout ratio is currently 15.86%.
COPYRIGHT VIOLATION NOTICE: This news story was posted by Ticker Report and is owned by of Ticker Report. If you are accessing this news story on another site, it was copied illegally and republished in violation of United States & international copyright & trademark laws. The correct version of this news story can be viewed at https://www.tickerreport.com/banking-finance/3296651/danaher-co-dhr-receives-102-61-consensus-target-price-from-brokerages.html.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.